What is next for DCTs after acceleration from COVID-19?
Tony Fantana
Advertisement
Lead, Emerging Technology Strategy – Clinical Design, Delivery & Analytics, Eli Lilly and Company
Articles by Tony Fantana
Advertisement
Latest Updated Articles
How Remote Patient Monitoring Technology Can Impact Decentralized Clinical TrialsPublished: September 16th 2022 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
2
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
3
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
4
Rethinking Operational Models to Reduce Site Burden in 2026
5